Incyte (INCY) Stock
NASDAQ · INCY
125.31
Fundamentals
Market cap
$25.40B
Price / Earnings ratio
16.0x
Price / Sales ratio
4.5x
Price / Book ratio
4.1x
Return on assets
0.2%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Incyte
Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives.Our unique expertise in medicinal chemistry and biology have enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists.
SectorHealthcare
IndustryBiotechnology
Employees2,844
CEOMr. William J. Meury
IPO DateNov 4, 1993
HeadquartersWilmington, DE
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. William J. Meury | CEO & Director | 1968 |
| Dr. Pablo J. Cagnoni M.D., Ph.D. | President and Global Head of R&D | 1963 |
| Mr. Thomas Tray | Principal Financial Officer, VP of Finance & Chief Accounting Officer | 1978 |
| Dr. Steven H. Stein M.D. | Executive VP, Head of Late-stage Development & Chief Medical Officer | 1967 |
| Mr. Mohamed Khairie Issa | Executive Vice President & Head of U.S. Commercial | 1983 |
| Mr. Suketu P. Upadhyay | Executive VP & CFO | 1969 |
| Mr. Michael James Morrissey | Executive VP & Head of Global Technical Operations | 1964 |
| Ms. Alexis Smith | VP & Head of Investor Relations | — |
| Mr. Richard A. Hoffman J.D., M.B.A. | Executive VP, General Counsel & Secretary | 1962 |
| Ms. Pamela M. Murphy | VP of Investor Relations & Corporate Communications | 1951 |
Fundamentals
Valuation
Market cap$25.40B
Price-to-sales ratio4.45
Price-to-book value4.08
Price-earnings ratio16.00
Return on Equity29.00%
Return on Sales0.33%
Return on Assets0.22%
PEG ratio10.82
Earnings Per Share
Earnings Per Share$8.12
Income Statement
Average volume1,285,790
EBITDA$1.87B
1 year high (52w)$132.60
1 year low (52w)$81.09
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



